Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168763 · ClinicalTrials.gov registry record · NA
Effect of Physician Attire on Patients' Preference of Physician
A NA study of Malignant Neoplasms of Independent (Primary) Multiple Sites, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT03168763: Completed NA study of Malignant Neoplasms of Independent (Primary) Multiple Sites, sponsored by M.D. Anderson Cancer Center.
NCT03168763 is a NA study of Malignant Neoplasms of Independent (Primary) Multiple Sites that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 108 participants, above the 74-participant average among 4 other Malignant Neoplasms of Independent (Primary) Multiple Sites trials with a reported enrollment target (46% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03168763, a NA study of Malignant Neoplasms of Independent (Primary) Multiple Sites, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn about the effects of a doctor's characteristics on participant's preference for a doctor. Researchers also want to learn about how a doctor's characteristics affect participant's options about professionalism and compassion.
Primary Outcome
Participant's rating of physician's compassion assessed by using a validated 5-item tool consisting of five 0-10 numerical rating scales assessing five dimensions: warm-cold, pleasant-unpleasant, compassionate- distant, sensitive- insensitive, and caring-uncaring. The sum of the five scales gives a final score representing physician's compassion on a scale of 0 to 50.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Video
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2017-09-25 |
| Est. Completion | 2020-10-26 |
| Phase | NA |
What the finished NCT03168763 record still lists
NCT03168763 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, above the 74-participant average among 4 other Malignant Neoplasms of Independent (Primary) Multiple Sites trials with a reported enrollment target (46% higher).
The record links to 1 condition, with Malignant Neoplasms of Independent (Primary) Multiple Sites appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT03168763 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03168763 about?
NCT03168763 is a clinical study titled "Effect of Physician Attire on Patients' Preference of Physician". The goal of this research study is to learn about the effects of a doctor's characteristics on participant's preference for a doctor. Researchers also want to learn about how a doctor's characteristics affect participant's options about professionalism and compassion.
What is the current status of trial NCT03168763?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2017-09-25. Estimated completion is 2020-10-26.
What conditions does trial NCT03168763 study?
This clinical trial studies the following conditions: Malignant Neoplasms of Independent (Primary) Multiple Sites.
What interventions are being tested in trial NCT03168763?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Video (BEHAVIORAL).
Who is sponsoring clinical trial NCT03168763?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03168763 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasms of Independent (Primary) Multiple Sites
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Communication Strategies to Introduce Psychology Services
COMPLETED · NA
-
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
RECRUITING · Phase 1
-
Expectations Regarding Mobility and Self-Care
ACTIVE NOT RECRUITING
-
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI